148 related articles for article (PubMed ID: 10494179)
1. [Evaluation of transplantation material based on immunophenotype and in vitro clonogenic assays of hematopoietic stem and progenitor cells].
Balana-Nowak A; Zdziłowska E; Szostek M; Skotnicki AB
Przegl Lek; 1999; 56 Suppl 1():28-33. PubMed ID: 10494179
[TBL] [Abstract][Full Text] [Related]
2. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
[TBL] [Abstract][Full Text] [Related]
3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
4. [General characteristics, basis and procedures for high dose chemotherapy procedures supported by hemopoietic stem cell transplantation].
Skotnicki AB; Zawirska D; Nowak W
Przegl Lek; 1999; 56 Suppl 1():10-6. PubMed ID: 10494176
[TBL] [Abstract][Full Text] [Related]
5. [High-dose chemotherapy with stem cell support for solid tumors in adults].
Rodenhuis S; de Vries EG
Ned Tijdschr Geneeskd; 1999 Apr; 143(14):731-8. PubMed ID: 10347628
[TBL] [Abstract][Full Text] [Related]
6. [High dose therapy with transplantation of autologous peripheral hematopoietic stem cells. I. Basic principles and clinical development].
Gunsilius E; Petzer A; Gastl G
Acta Med Austriaca; 1997; 24(3):97-101. PubMed ID: 9312975
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
[TBL] [Abstract][Full Text] [Related]
8. Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34(+) enriched hematopoietic progenitor cells from partially mismatched related donors.
Redei I; Langston AA; Lonial S; Cherry JK; Allen AJ; Hamilton E; Jones M; Bartlett VM; Waller EK
Bone Marrow Transplant; 2002 Sep; 30(6):335-40. PubMed ID: 12235516
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study on single-dose rhG-CSF combined with chemotherapy in autologous peripheral blood stem cell transplantation].
Tian H; Zhou SY
Ai Zheng; 2002 Aug; 21(8):896-9. PubMed ID: 12478902
[TBL] [Abstract][Full Text] [Related]
10. Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy.
Blystad AK; Delabie J; Kvaløy S; Holte H; Vålerhaugen H; Ikonomou I; Kvalheim G
Br J Haematol; 2004 Jun; 125(5):605-12. PubMed ID: 15147376
[TBL] [Abstract][Full Text] [Related]
11. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
[TBL] [Abstract][Full Text] [Related]
12. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.
Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G
Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993
[TBL] [Abstract][Full Text] [Related]
13. Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant.
Devine SM; Sanborn R; Jessop E; Stock W; Huml M; Peace D; Wickrema A; Yassine M; Amin K; Thomason D; Chen YH; Devine H; Maningo M; van Besien K
Bone Marrow Transplant; 2001 Sep; 28(6):557-62. PubMed ID: 11607768
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of epirubicin/paclitaxel combination in mobilizing large amounts of hematopoietic progenitor cells in patients with metastatic breast cancer showing optimal response to the same chemotherapy regimen.
Zibera C; Pedrazzoli P; Ponchio L; Gibelli N; Lanza A; Da Prada GA; Zambelli A; Perotti C; Torretta L; Salvaneschi L; Robustelli della Cuna G
Haematologica; 1999 Oct; 84(10):924-9. PubMed ID: 10509041
[TBL] [Abstract][Full Text] [Related]
15. [The use of peripheral blood progenitor cells as an autologous hematopoietic support in high-dose chemotherapy. II. The experience of the Hematological Intensive Care Unit of the IPOFG. Franciso Gentil Portuguese Institute of Oncology].
Silva MR; Passos-Coelho JL; da Costa FL; Machado MA; Miranda N; Miranda MH; Parreira A
Acta Med Port; 1999; 12(7-11):275-81. PubMed ID: 10707465
[TBL] [Abstract][Full Text] [Related]
16. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
[TBL] [Abstract][Full Text] [Related]
17. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies.
Alessandrino EP; Bernasconi P; Colombo A; Caldera D; Martinelli G; Vitulo P; Malcovati L; Nascimbene C; Varettoni M; Volpini E; Klersy C; Bernasconi C
Bone Marrow Transplant; 2000 Feb; 25(3):309-13. PubMed ID: 10673703
[TBL] [Abstract][Full Text] [Related]
19. [Mobilization of autologous peripheral blood stem cells by combined chemotherapy and rhG-CSF].
Shi H; Gu X; Zhu L
Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):159-61. PubMed ID: 11783025
[TBL] [Abstract][Full Text] [Related]
20. High-dose therapy in multiple myeloma: effect of positive selection of CD34+ peripheral blood stem cells on hematologic engraftment and clinical outcome.
Patriarca F; Damiani D; Fanin R; Grimaz S; Geromin A; Cerno M; Sperotto A; Silvestri F; Zaja F; Baccarani M
Haematologica; 2000 Mar; 85(3):269-74. PubMed ID: 10702815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
